Skip to main content
SpringerLink
Log in

The effect of acute and repeated electroconvulsive treatment on plasma β-endorphin, growth hormone, prolactin and cortisol secretion in depressed patients

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

The effects of single and repeated electroconvulsive treatment (ECT) on β-endorphin (β-EP), cortisol, growth hormone (GH) and prolactin (Prl) plasma levels were investigated in nine depressed patients. Blood samples were monitored a day before ECT, the day of the first and sixth ECT (0, 30, 60 and 90 min after seizures), the day afterwards and 4 weeks after termination of the ECT course.

A significant elevation of β-EP levels was achieved immediately with and 24 h after the first and the sixth ECT. A transient increase in basal β-EP was observed 1 day following the sixth ECT in comparison with pre-treatment level. Peak and 30 min levels of cortisol were increased compared with baseline by the first ECT. The former (peak) but not the latter (30 min) were increased also at the sixth treatment. GH levels were decreased the day after the first ECT in comparison with the pre-treatment levels and immediately following each ECT in comparison with baseline. A trend toward elevation of Prl was observed immediately after the first and sixth ECT, although the rise did not reach significant levels. ECT administration stimulated β-EP and cortisol secretion and suppressed human GH release, possibly by activation of endorphinergic and/or serotonergic systems. These mechanisms might be involved in the beneficial effect of ECT in depression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Alexopoulos GS, Inturrissi CE, Lipman R, Frances R, Haycox J, Dougherty JH, Rossier J (1983) Plasma immunoreactive β-endorphin levels in depression. Arch Gen Psychiatry 40:181–183

    PubMed  CAS  Google Scholar 

  • American Psychiatric Association (1980) Diagnostic and statistical manual of mental disorders (3rd ed). Washington, DC

  • Aperia B, Thoren M, Zettergren M, Wettenberg L (1984) Plasma pattern of adrenocorticotropin and cortisol during electroconvulsive therapy in patients with major depressive illness. Acta Psychiatr Scand 70:361–369

    PubMed  CAS  Google Scholar 

  • Arato M, Bagdy G (1982) Neuroendocrine study of the mechanism of action of electroconvulsive therapy. Neuropsychobiology 8:162–168

    PubMed  CAS  Google Scholar 

  • Balldin J (1982) Factors influencing prolactin release induced by electroconvulsive therapy. Acta Psychiatr Scand 65:365–369

    PubMed  CAS  Google Scholar 

  • Beck AT, Beamesderfer A (1974) Assessment of depression: The depression inventory. Mod Probl Pharmacopsychiatry 7:151–169

    PubMed  CAS  Google Scholar 

  • Belenky GL, Holaday JW (1979) The opiate antagonist naloxone modifies the effects of electroconvulsive shock (ECS) on respiration, blood pressure and heart rate. Brain Res 177:414–417

    Article  PubMed  CAS  Google Scholar 

  • Belenky GL, Holaday JW (1980) Electroconvulsive shock (ECS) in rats: Naloxone modification of post-ECS behaviors provides evidence for functional endorphin release. In: Way EL (ed) Endogenous and exogenous opiate agonists and antagonists, Pergamon, New York, pp 487–490

    Google Scholar 

  • Bruni JF, Hawkins RL, Yen SSC (1982) Serotonergic mechanism in the control of β-endorphin and ACTH release in male rats. Life Sci 30:1247–1254

    Article  PubMed  CAS  Google Scholar 

  • Clement-Jones V, Besser GM (1983) Clinical perspectives in opioid peptides. Br Med Bull 39:95–100

    PubMed  CAS  Google Scholar 

  • Deakin JFW, Ferrier IN, Crow TJ, Johnston EC, Lawler P (1983) Effects of ECT on pituitary hormone release: Relationship to seizure, clinical variable and outcome. Br J Psychiatry 143:618–624

    PubMed  CAS  Google Scholar 

  • d'Elia G, Raotma H (1975) Is unilateral ECT less effective than bilateral ECT. Br J Psychiatry 126:83–89

    PubMed  Google Scholar 

  • deMontigny C (1984) Electroconvulsive shock treatments enhance responsiveness of forebrain neurons to serotonin. J Pharmacol Exp Ther 228:230–234

    CAS  Google Scholar 

  • Emrich HM, Holt V, Kissling W, Fischler M, Heineman H, von Zersson D, Herz A (1979) Measurement of β-endorphin-like immunoreactivity in CSF and plasma of neuropsychiatric patients. Adv Exp Med Biol 116:307–317

    PubMed  CAS  Google Scholar 

  • Grahame-Smith DG, Green AR, Costain DW (1978) Mechanism of the antidepressant action of electroconvulsive therapy. Lancet I:245–256

    Google Scholar 

  • Guillemin R, Vargo T, Rossier J, Minick S, Ling N, Rivier C, Vale W, Bloom F (1977) β-Endorphin and adrenocorticotropin are secreted concomitantly by the pituitary gland. Science 197:1367–1369

    PubMed  CAS  Google Scholar 

  • Haskett RF, Zis AP, Albala AA (1985) Hormone response to repeated electroconvulsive therapy: effects of naloxone. Biol Psychiatry 20:623–633

    Article  PubMed  CAS  Google Scholar 

  • Hong JS, Gillin JC, Yang HYT, Costa E (1979) Repeated electroconvulsive shocks and the brain content of endorphins. Brain Res 177:273–278

    Article  PubMed  CAS  Google Scholar 

  • Janowsky D, Judd L, Huly L, Roitman N, Parker D, Segal D (1978) Naloxone effects on manic symptoms and growth hormone levels. Lancet II:320

    Article  Google Scholar 

  • Katz RJ, Schmaltz K (1980) Reduction in opiate activation after chronic electroconvulsive shock: Possible role for endorphins in the behavioral effects of convulsive shock treatment. Neurosci Lett 19:85–88

    Article  PubMed  CAS  Google Scholar 

  • Kendell RE (1981) The present status of electroconvulsive therapy. Br J Psychiatry 139:265–283

    PubMed  CAS  Google Scholar 

  • Kline NS, Li CH, Lehmann HE, Lajtha A, Laski E, Cooper T (1979) β-Endorphin-induced changes in schizophrenic and depressed patients. Arch Gen Psychiatry 34:1111–1113

    Google Scholar 

  • Lal S, Tolis G, Martin JB, Brown GM, Guyda H (1975) Effect of clonidine on growth hormone, prolactin, luteinizing hormone, follicle-stimulating hormone and thyroid-stimulating hormone in the serum of normal man. J Clin Endocrinol Metab 41:827–832

    PubMed  CAS  Google Scholar 

  • Lewis DA, Sherman BM (1984) Serotonergic stimulation of adrenocorticotropin secretion in man. J Clin Endocrinol Metab 58:458–462

    PubMed  CAS  Google Scholar 

  • Lindstrom LH, Widerlov LM, Gunne L, Wahlstrom A, Terenius L (1978) Endorphins in cerebrospinal fluid: Clinical correlations of some psychotic states. Acta Psychiatr Scand 57:153–164

    PubMed  CAS  Google Scholar 

  • Linnoila M, Litovitz G, Scheinin M, Chang MD, Culter NR (1984) Effects of electroconvulsive treatment on monoamine metabolites, growth hormone and prolactin in plasma. Biol Psychiatry 19:79–84

    Article  PubMed  CAS  Google Scholar 

  • Mandel MR (1975) Electroconvulsive therapy for chronic pain associated with depression. Am J Psychiatry 132:632–636

    PubMed  CAS  Google Scholar 

  • Meyer JS, McElroy JF, Yehuda R, Miller J (1984) Serotonergic stimulation of pituitary adrenocortical activity in rats: Evidence for multiple sites of action. Life Sci 34:1891–1898

    Article  PubMed  CAS  Google Scholar 

  • Misiaszek J, Cork RC, Hameroff SR, Finley J, Weiss JL (1984) The effect of electroconvulsive therapy on plasma β-endorphin. Biol Psychiatry 19:451–455

    PubMed  CAS  Google Scholar 

  • O'Dea JPK, Gould D, Hallberg M, Wieland R (1978) Prolactin changes during electroconvulsive therapy. Am J Psychiatry 135:609–611

    PubMed  Google Scholar 

  • Pilc A, Vetulani J (1982) Depression by chronic electroconvulsive treatment of clonidine hypothermia and [3H]clonidine binding to rat cortical membranes. Eur J Pharmacol 80:109–113

    Article  PubMed  CAS  Google Scholar 

  • Prange-Hansen D (1971) The effect of adrenergic receptor blockade on the exercise-induced serum growth hormone rise in normals and juvenile diabetics. J Clin Endocrinol Metab 33:807–812

    Article  Google Scholar 

  • Risch SC (1982) β-Endorphin hypersecretion in depression: Possible cholinergic mechanisms. Biol Psychiatry 17:1071–1079

    PubMed  CAS  Google Scholar 

  • Siever LJ, Murphy DL, Slater S, de la Vega E, Lipper S (1984) Plasma prolactin changes following fenfluramine in depressed patients compared to controls: An evaluation of central serotonergic responsivity in depression. Life Sci 34:1029–1039

    Article  PubMed  CAS  Google Scholar 

  • Skrabanek A, Balfe A, Webb M, Maguire J, Powell D (1981) Electroconvulsive therapy (ECT) increases plasma growth hormone, prolactin, luteinizing hormone and follicle-stimulating hormone but not thyrotropin or substance P. Psychoneuroendocrinology 6:261–267

    Article  PubMed  CAS  Google Scholar 

  • Swartz C, Abrams R (1984) Prolactin levels after bilateral and unilateral ECT. Br J Psychiatry 44:643–645

    Article  Google Scholar 

  • Vetulani J, Lebrecht V, Pilc A (1981) Enhancement of responsiveness to the central serotonergic system and serotonin-2 receptor density in rat frontal cortex by electroconvulsive treatment. Eur J Pharmacol 76:81–85

    Article  PubMed  CAS  Google Scholar 

  • Weiner RI, Ganong WF (1978) Role of brain monoamines and histamine in regulation of anterior pituitary secretion. Physiol Rev 58:905–976

    PubMed  CAS  Google Scholar 

  • Whalley LJ, Dick H, Watts AG, Christie JE, Rosie R, Levy G, Sheward WJ, Fink G (1982) Immediate increases in plasma prolactin and neurophysin but not other hormones after electroconvulsive therapy. Lancet II:1064–1068

    Article  Google Scholar 

  • Zis AP, Haskett RF, Albala A, Carroll BJ, Lohr NE (1985) Opioid regulation of hypothalamic-pituitary-adrenal function in depression. Arch Gen Psychiatry 42:383–386

    PubMed  CAS  Google Scholar 

Download references

Author information

Author notes

  1. A. Weizman

    Present address: Clinical Neuroscience Branch, National Institute of Mental Health, Bldg 10, Rm 4N214, 9000 Rockville Pike, 20892, Bethesda, MD, USA

Authors and Affiliations

  1. Sackler Faculty of Medicine, Geha Psychiatric Hospital, Beilinson Medical Center, Petah Tiqva, and Tel Aviv University, Israel

    A. Weizman, D. Grupper & S. Tyano

  2. Sackler Faculty of Medicine, Institute of Pediatric and adolescent Endocrinology, Beilinson Medical Center, Petah Tiqva, and Tel Aviv University, Israel

    I. Gil-Ad & Z. Laron

Authors
  1. A. Weizman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I. Gil-Ad
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. Grupper
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Tyano
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Z. Laron
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Weizman, A., Gil-Ad, I., Grupper, D. et al. The effect of acute and repeated electroconvulsive treatment on plasma β-endorphin, growth hormone, prolactin and cortisol secretion in depressed patients. Psychopharmacology 93, 122–126 (1987). https://doi.org/10.1007/BF02439598

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02439598

Key words

Search

Navigation